1-tert-Butyl 3-methyl 3-ethylazetidine-1,3-dicarboxylate, 95.0%, 1g

(2,4-DIHYDROXY-5-ISOPROPYLPHENYL)(5-((4-METHYLPIPERAZIN-1-YL)METHYL)ISOINDOLIN-2-YL)METHANONE, 98%, 250mg

3-Butoxyphenylboronic Acid (contains varying amounts of Anhydride)5g

Impact magnifier. Magnification: 20x triplet. With Achromatic lens Ø 20 mm. Field of view 8 mm

(Z)-Methyl 3-(((4-acetamidophenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate (Nintedanib Impurity), 97%, 50mg

3-(1-(tert-Butoxy)-2-methyl-1-oxopropan-2-yl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-6-carboxylic acid, 98%, 100mg

2,5-Dichloropyridine-4-boronic acid, 96.0%, 100g

Palladium wire 99.9% 0.25 mm diameter 1 m

(1R,2S)-1-tert-Butyl 2-ethyl cyclohexane-1,2-dicarboxylate, 95.0%, 250mg

N-(2-(1-(2-((2,3-Dihydro-1H-inden-5-yl)amino)-2-oxoethyl)-1H-benzo[d]imidazol-2-yl)ethyl)-N-methylbenzamide, 98%, 25mg

4-(tert-Butoxycarbonylaminomethyl)piperidine, 97.0%, 1g

5-Bromo-2-fluoro-3-pyridylboronic acid, 97.0%, 25g

BENZYLDIPHENYLPHOSPHINE OXIDE, 95.0%, 250mg